Oriola Oyj (FRA:O5O)

Market Cap	216.00M +28.5%
Revenue (ttm)	1.85B +13.5%
Net Income	-27.10M
EPS	-0.15
Shares Out	n/a
PE Ratio	n/a
Forward PE	11.73
Dividend	0.07 (5.92%)
Ex-Dividend Date	Apr 3, 2025

Volume	n/a
Average Volume	14
Open	1.182
Previous Close	1.200
Day's Range	1.182 - 1.182
52-Week Range	0.897 - 1.240
Beta	n/a
RSI	51.28
Earnings Date	Feb 25, 2026

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1907
• Employees: 801
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: O5O

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.